Clinical TrialsSearch results
Number of results: 2568
Other
- Phase 2 study for SAR443820 in participants with amyotrophic lateral sclerosis (ALS)
- Amyotrophic lateral sclerosis
- Tanaka Tomoyuki
- 2022-05-19
Other
- Observational study of a motion capture device (AKIRA) in patients with ALS
- Amyotrophic Lateral Sclerosis
- Hirai Manabu
- 2024-02-22
Not yet recruiting
- A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
- Amyotrophic Lateral Sclerosis in patients with FUS-ALS
- Rebecca Crean
- 2024-05-22
Recruiting
- Evaluation of a consumer wearable device compared to polysomnography for detecting sleep
- An exploration of wearable devices for sleep evaluation in healthy people
- Svensson Kishi Akiko
- 2021-12-16
Other
- Anal carcinoma study
- Anal carcinoma
- Ando Naokatsu
- 2022-03-07
Completed
- Skin test and flow cytometry in healthy volunteers to establish the method for determining causative drug of perioperative anaphylaxis: A preliminary study
- anaphylaxis
- Takazawa Tomonori
- 2021-01-19
Other
- JCOG1016: Phase III randomized study for anaplastic glioma of radiotherapy with temozolomide vs. ACNU followed by temozolomide
- anaplastic glioma
- MURAGAKI Yoshihiro
- 2019-03-08
Other
- Rituximab treatment of cyclophosphamide-resistant patients with ANCA-associated vasculitis
- ANCA-associated vasculitis
- Research Comittee of Intractable Vasculitis Syndrome of the Ministry of Health, Labor and Welfare of Japan
- 2007-12-01
Completed
- Phase II Trial of Endocrine therapy for patients with Metastatic extramammary Paget's disease ExpRessing Androgen-Receptor using Darolutamide with/without LH-RH agonist.
- Androgen receptor positive advanced stage extramammary Paget's disease
- Nakamura Yoshio
- 2022-12-13
Other
- Phase II study of Darolutamide (ODM-201) in patients with androgen receptor-positive salivary gland carcinoma
- Androgen receptor-positive salivary gland carcinoma
- Tahara Makoto
- 2020-03-04